A systematic review of economic analyses of HER2 testing & trastuzumab therapy

被引：0
|
作者：
Ferrusi, I. L. [1 ]
Marshall, D. A. [1 ]
Kulin, N. A. [1 ]
Phillips, K. A. [2 ]
机构：
[1] McMaster Univ, Hamilton, ON, Canada
[2] Univ Calif San Francisco, San Francisco, CA 94143 USA
来源：
VALUE IN HEALTH | 2008年 / 11卷 / 03期
关键词：
D O I：
10.1016/S1098-3015(10)70194-7
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：A58 / A58
页数：1
相关论文
共 50 条
  • [1] Looking back at 10 years of trastuzumab therapy: what is the role of HER2 testing? A systematic review of health economic analyses
    Ferrusi, Ilia L.
    Marshall, Deborah A.
    kulin, Nathalie A.
    Leighl, Natasha B.
    Phillips, Kathryn A.
    PERSONALIZED MEDICINE, 2009, 6 (02) : 193 - 215
  • [2] HER2 testing and correlation with efficacy of trastuzumab therapy
    Fornier, M
    Risio, M
    Van Poznak, C
    Seidman, A
    ONCOLOGY-NEW YORK, 2002, 16 (10): : 1340 - +
  • [3] Pharmacodiagnostic testing in breast cancer - Focus on HER2 and trastuzumab therapy
    Bartlett, JMS
    AMERICAN JOURNAL OF PHARMACOGENOMICS, 2005, 5 (05) : 303 - 315
  • [4] Systematic Review of HER2 Breast Cancer Testing
    Cuadros, Marta
    Villegas, Roman
    APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY, 2009, 17 (01) : 1 - 7
  • [5] The role of Trastuzumab Emtansine as a novel-targeted therapy for HER2 breast cancer: A systematic review
    Bajaj, Nikki
    Shaaban, Hamid
    Guron, Gunwant
    Maroules, Michael
    CLINICAL CANCER INVESTIGATION JOURNAL, 2013, 2 (04): : 275 - 280
  • [6] Cost-effectiveness of HER2 testing and trastuzumab therapy for metastatic breast cancer
    Lidgren, Mathias
    Wilking, Nils
    Jonsson, Bengt
    Rehnberg, Clas
    ACTA ONCOLOGICA, 2008, 47 (06) : 1018 - 1028
  • [7] HER2 therapy: Molecular mechanisms of trastuzumab resistance
    Rita Nahta
    Francisco J Esteva
    Breast Cancer Research, 8
  • [8] HER2 therapy - Molecular mechanisms of trastuzumab resistance
    Nahta, Rita
    Esteva, Francisco J.
    BREAST CANCER RESEARCH, 2006, 8 (06):
  • [9] TRASTUZUMAB EMTANSINE FOR HER2 POSITIVE BREAST CANCER PATIENTS: AN UPDATED SYSTEMATIC REVIEW
    Valle, P. M.
    Mosegui, G. B.
    Vianna, C. M.
    Araujo, R. L.
    Felicissimo, T.
    Lima, I. J.
    VALUE IN HEALTH, 2015, 18 (07) : A816 - A816
  • [10] Lapatinib and lapatinib plus trastuzumab therapy versus trastuzumab therapy for HER2 positive breast cancer patients: an updated systematic review and meta-analysis
    Ye Yuan
    Xumei Liu
    Yi Cai
    Wenyuan Li
    Systematic Reviews, 11
12345